(NASDAQ: SRRK) Scholar Rock Holding's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 115.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 24.07%.
Scholar Rock Holding's revenue in 2026 is $0.On average, 17 Wall Street analysts forecast SRRK's revenue for 2026 to be $4,190,466,334, with the lowest SRRK revenue forecast at $0, and the highest SRRK revenue forecast at $9,661,126,252. On average, 15 Wall Street analysts forecast SRRK's revenue for 2027 to be $21,475,629,922, with the lowest SRRK revenue forecast at $7,497,548,090, and the highest SRRK revenue forecast at $39,403,440,490.
In 2028, SRRK is forecast to generate $41,920,984,529 in revenue, with the lowest revenue forecast at $15,994,769,258 and the highest revenue forecast at $68,023,672,700.